Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malaria

Fig. 2

Treatment with artesunate is associated with reduced systemic inflammation at 1-month follow-up. Box and whisker plots showing the median (interquartile range) and 95% confidence interval of plasma CRP levels measured on enrollment and at 1-month follow-up. The p values on the graph are derived from linear regression models adjusting for child age, sex, and treatment group in the iron study

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us